Skip to main content
. Author manuscript; available in PMC: 2018 Feb 17.
Published in final edited form as: ACS Chem Biol. 2017 Jan 9;12(2):357–361. doi: 10.1021/acschembio.6b00854

Figure 3.

Figure 3

Intact mass spectra of N332A gp120 (black) and wild-type (WT) gp120 (blue) expressed in the presence of kifunensine. The number of N-glycosylation sites at each cluster of peaks is indicated (n). WT and the N332A mutant of BG505 gp120 have a maximum N-glycosylation site occupancy potential of n = 24 and 23, respectively.